C12Y 302/01114
Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase
Official title: Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (3.2.1.114)
C12Y302/01114 (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) appears on 9 US grants and 15 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 15
- Assignees
- 11
- Inventors
- 24
- Latest grant
- 18 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Yeast strains producing mammalian-like complex n-glycans18 Jan 2022US 11,225,646 B2Oxyrane UK Limited
- Yeast strains producing mammalian-like complex N-glycans14 May 2019US 10,287,557 B2Oxyrane UK Limited
- Protein glycosylation modification in methylotrophic yeast11 Nov 2014US 8,883,445 B2Research Corporation Technologies, Inc.
- Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function14 Oct 2014US 8,859,234 B2Roche Glycart AG
- Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function5 Feb 2013US 8,367,374 B2Roche Glycart AG
- Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof10 Jul 2025US 2025/0223364 A1Dren Bio, Inc.
- Yeast strains producing mammalian-like complex n-glycans1 Aug 2019US 2019/0233802 A1Oxyrane UK Limited
- Yeast strains producing mammalian-like complex n-glycans26 Nov 2015US 2015/0337273 A1Oxyrane UK Limited
- Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function13 Mar 2014US 2014/0073005 A1Roche Glycart AG
- Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells10 Oct 2013US 2013/0266981 A1GlycoFi, Inc.
Most cited
By later US patents
- Protein glycosylation modification in methylotrophic yeast18US 7,252,933 B2Flanders Interuniversity Institute for Biotechnology · 2007
- Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells13US 7,625,756 B2GycoFi, Inc. · 2009
- Protein glycosylation modification in methylotrophic yeast11US 8,883,445 B2Research Corporation Technologies, Inc. · 2014
- Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function5US 8,367,374 B2Roche Glycart AG · 2013
- Yeast strains producing mammalian-like complex N-glycans4US 10,287,557 B2Oxyrane UK Limited · 2019